Diego Novick

4.7k total citations · 1 hit paper
128 papers, 3.6k citations indexed

About

Diego Novick is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Diego Novick has authored 128 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Psychiatry and Mental health, 38 papers in Pharmacology and 24 papers in Clinical Psychology. Recurrent topics in Diego Novick's work include Schizophrenia research and treatment (61 papers), Bipolar Disorder and Treatment (38 papers) and Treatment of Major Depression (31 papers). Diego Novick is often cited by papers focused on Schizophrenia research and treatment (61 papers), Bipolar Disorder and Treatment (38 papers) and Treatment of Major Depression (31 papers). Diego Novick collaborates with scholars based in United Kingdom, Spain and United States. Diego Novick's co-authors include Josep María Haro, David L. Suarez, Catherine Reed, Jihyung Hong, Jordi Alonso, Peter Haddad, William Montgomery, Regina Dittmann, Dieter Naber and Peter B. Jones and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Spine.

In The Last Decade

Diego Novick

125 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

2003 511 citations Josep María Haro, Diego Novick et al. Acta Psychiatrica Scandinavica profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Diego Novick	2.7k	924	654	544	484	128	3.6k
Haya Ascher‐Svanum	3.7k 1.4×	1.2k 1.3×	834 1.3×	517 1.0×	517 1.1×	143	4.5k
Maxine X. Patel	2.3k 0.9×	823 0.9×	647 1.0×	299 0.5×	246 0.5×	62	3.2k
A. George Awad	3.6k 1.3×	1.7k 1.8×	948 1.4×	442 0.8×	757 1.6×	80	4.6k
Katja Komossa	3.0k 1.1×	756 0.8×	519 0.8×	545 1.0×	269 0.6×	26	4.3k
Lakshmi N.P. Voruganti	1.9k 0.7×	1.0k 1.1×	450 0.7×	282 0.5×	493 1.0×	34	2.5k
Christine Rummel‐Kluge	2.0k 0.7×	1.4k 1.6×	356 0.5×	365 0.7×	766 1.6×	109	4.2k
Jose Ma. J. Alvir	3.1k 1.1×	1.2k 1.3×	738 1.1×	297 0.5×	300 0.6×	37	4.4k
Anne Karow	2.1k 0.8×	1.2k 1.3×	769 1.2×	175 0.3×	539 1.1×	107	3.2k
Frédéric Rouillon	2.0k 0.7×	1.9k 2.0×	304 0.5×	447 0.8×	567 1.2×	103	4.5k
María Paz García‐Portilla	2.3k 0.8×	1.4k 1.5×	308 0.5×	280 0.5×	570 1.2×	271	4.7k

Countries citing papers authored by Diego Novick

Since Specialization

Citations

This map shows the geographic impact of Diego Novick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Novick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Novick more than expected).

Fields of papers citing papers by Diego Novick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Novick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Novick. The network helps show where Diego Novick may publish in the future.

Co-authorship network of co-authors of Diego Novick

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Novick. A scholar is included among the top collaborators of Diego Novick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Novick. Diego Novick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nozawa, Kazuki, Mitsuo Terada, Yukinori Ozaki, et al.. (2023). Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan. Breast Cancer. 30(4). 657–665. 7 indexed citations

Hattori, Masaya, Diego Novick, Kana Takaura, et al.. (2021). A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan. Japanese Journal of Clinical Oncology. 51(10). 1498–1508. 4 indexed citations

Novick, Diego, Guillermo Méndez, Marcela Carballido, et al.. (2019). Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina. SHILAP Revista de lepidopterología. 19(8). e7693–e7693. 1 indexed citations

Huang, Jia, Yun Wang, Jun Chen, et al.. (2018). Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline. Neuropsychiatric Disease and Treatment. Volume 14. 2473–2484. 6 indexed citations

Novick, Diego, et al.. (2017). Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study. Patient Preference and Adherence. Volume 11. 1859–1868. 24 indexed citations

Novick, Diego, Qiang Shi, Yue Li, et al.. (2017). Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong. Asia-Pacific Psychiatry. 10(2). e12295–e12295. 4 indexed citations

Novick, Diego, William Montgomery, Tamás Treuer, et al.. (2017). Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder. Patient Preference and Adherence. Volume 11. 1019–1025. 10 indexed citations

Novick, Diego, William Montgomery, Tamás Treuer, María Victoria Moneta, & Josep María Haro. (2016). Sex differences in the course of schizophrenia across diverse regions of the world. Neuropsychiatric Disease and Treatment. Volume 12. 2927–2939. 30 indexed citations

Novick, Diego, William Montgomery, Jaume Aguado, Xiaomei Peng, & Josep María Haro. (2016). Factors associated with and impact of pain persistence in Asian patients with depression: a 3-month, prospective observational study. International Journal of Psychiatry in Clinical Practice. 21(1). 29–35. 5 indexed citations

10.

Novick, Diego, William Montgomery, María Victoria Moneta, et al.. (2015). Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?. International Journal of Psychiatry in Clinical Practice. 19(3). 174–181. 5 indexed citations

11.

Novick, Diego, William Montgomery, Jaume Aguado, et al.. (2015). Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder?. Asia-Pacific Psychiatry. 7(4). 427–435. 19 indexed citations

12.

Novick, Diego, et al.. (2015). Impact of Negative Symptoms on Quality of Life in Patients with Schizophrenia. Value in Health. 18(7). A836–A837. 8 indexed citations

13.

Hong, Jihyung, Diego Novick, Tamás Treuer, et al.. (2014). Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia. BMC Psychiatry. 14(1). 304–304. 7 indexed citations

14.

Novick, Diego, William Montgomery, Tamás Treuer, et al.. (2014). Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients: Results from a 1-Year European Outpatient Observational Study. Value in Health. 17(7). A766–A766. 1 indexed citations

15.

Cui, Zhanglin Lin, Douglas E. Faries, Wei Shen, Stephen L. Able, & Diego Novick. (2013). Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine. Journal of Medical Economics. 16(5). 623–632. 1 indexed citations

16.

Novick, Diego, William Montgomery, Jaume Aguado, et al.. (2013). Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?. Journal of Affective Disorders. 149(1-3). 182–188. 71 indexed citations

17.

Sun, Simon, Diego Novick, Douglas E. Faries, et al.. (2012). SB1 Comparison of Medical Care Consumption Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia Patients. Value in Health. 15(4). A4–A4. 1 indexed citations

18.

Cui, Zhanglin Lin, et al.. (2011). Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective. Journal of Medical Economics. 15(1). 134–144. 7 indexed citations

19.

Novick, Diego, et al.. (2008). Incidence and characteristics of remission in schizophrenic patients: analysis of the results of the three-year SOHO study in Italy (Schizophrenia Outpatients Health Outcomes). Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology. 14. 1 indexed citations

20.

Haro, Josep María, E.T. Edgell, Diego Novick, et al.. (2004). Effectiveness of antipsychotic treatment for schizophrenia: 6‐month results of the Pan‐European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica. 111(3). 220–231. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact